LIBROS
Scheuer L, Black S, ed. Developmental juvenile osteology. Sidcup: Harcourt, 2000.
Burckhardt P, Dawson-Hughes B, Heaney RP, ed. Nutritional aspects of osteoporosis. New York: Harcourt Pub, 2001.
Cowin S, ed. Bone mechanics handbook. Boca Ratón; CRC Press, 2001.
Burr DB, C Milgrom, ed. Musculoskeletal fatigue & stress fractures. Boca Ratón: CRC Press, 2001.
An YH, Draughn RA, ed. Mechanical testing of bone and the bone-implant interface. Boca Ratón: CRC Press, 2001.
Bilezikian JP, Raisz LG, Rodan GA, ed. Principles of bone biology. Sicup: Harcourt, 2001.
Dahia PLM, Eng C, ed. Genetic disorders of endocrine neoplasia. Basel: Karger, 2001.
Schulkin J. Calcium hunger: Behavioral and biological regulation. New York: Cambridge University Press, 2001.
NUMEROS MONOGRAFICOS
C Lozano. Cuestiones clave en osteoporosis. Madrid: SCM, 2001.
NUESTROS AUTORES
Orozco P, Navarro MA, Nolla JM. Salivary testosterone is asociated with higher lumbar bone mass in premenopausal healthy women with normal levels of serum testosterone. Europ J Epidemiol 2000; 16: 907-912.
Gimeno C, Ferreti M, Ardizzoni A, et al. Osteocyte-osteoclast morphological relationships and the putative role of osteocytes in bone remodeling. J Musculoeskel Neuron Interact 2001; 1: 327-332.
Gimeno J, Azcona C, Sierra L. Medida de la densidad mineral ósea por osteosonografía en niños y adolescentes sanos. determinación de valores normales. An Esp Pediatr 2001; 54: 540-546.
Nolla JM, Fiter J, Gómez-Vaquero C, et al. Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry. Ann Rheum Dis 2001; 60: 799-801.
Pérez Jiménez F, Quesada JM. Las estatinas: un intrigante nexo entre la osteoporosis y la aterosclerosis. Med Clin (Barc) 2001; 116: 696-697.
Rico H, Aguado F, Arribas I, et al. Behaviour of phalangeal bone ultrasound on normal women with reaction to gonadal status and body mass index. Osteoporosis Int 2001; 12: 450-455.
Monegal A, Navasa M, Guanabens N, et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporosis Int 2001; 12: 484-492.
Mostaza JM, de la Piedra C, Díaz Curiel M, et al. Pravastatin therapy increases procollagen I N-terminal propeptine (PINP), a marker of bone formation in postmenopausal women. Clin Chim Acta 2001; 308: 133-137.
Blanch J. Risedronato y la familia de los difosfonatos en el tratamiento de la osteoporosis postmenopáusica. Osteoporosis 2001; 1: 5-13.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Endocr Pract 2001; 7: 294-312.
MacDonald BR, Gowen M. Emerging therapies in osteoporosis. Baillieres Best Pract Res Clin Rheumatol 2001; 15: 483-496.
Faulkner KG, Pocock N. Future methods in the assessment of bone mass and structure. Baillieres Best Pract Res Clin Rheumatol 2001; 15: 359-383.
Lau EM. Epidemiology of osteoporosis. Baillieres Best Pract Res Clin Rheumatol 2001; 15: 335-344.
Blake GM, Fogelman I. Peripheral or Central Densitometry: Does It Matter Which Technique We Use? J Clin Densitom 2001; 4: 83-96.
Fan SL, Cunningham J. Bisphosphonates in renal osteodystrophy. Curr Opin Nephrol Hypertens 2001; 10: 581-588.
Hofbauer LC, Schoppet M. Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 2001; 358: 257-259.
Hirsch PF, Lester GE, Talmage RV. Calcitonin, and enigmatic hormone: does it have a function? J Musculoeskel Neuron Interact 2001; 1: 299-306.
Lyles KW. Osteoporosis and depression: shedding more light upon a complex relationship. J Am Geriagr Soc 2001; 49: 827-828.
Van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001; 103: 255-261.
Garfin SR, Yuan HA, Reiley MA. New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures. Spine 2001; 26: 1.511-1.515.
Holley JL, Schmidt RJ. Hormone replacement therapy in postmenopausal women with end-stage renaldisease: a review of the issues. Semin Dial 2001; 14: 146-149.
Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann Med 2001; 33: 7-21.
Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27: 165-176.
Handoll HH, Madhok R. Conservative interventions for treating distal radial fractures in adults Cochrane Database Syst Rev 2001; 2: CD000314.
Brommage R. Perspectives on using nonhuman primates to understand the etiology and treatment of postmenopausal osteoporosis. J Musculoeskel Neuron Interact 2001; 1: 307-326.
Basaria S, Dobs AS. Hypogonadism and androgen replacement therapy in elderly men. Am J Med 2001; 110: 563-572.
Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Int Med 2001; 161: 1.161-1.172.
Currey JD. Bone strenght: What are we trying to measure? Calcif Tissue Int 2001; 68: 205-210.
Hock JM, Krishman V, Onyia JE, et al. Osteoblast apoptosis and bone turnover. J Bone Miner Res 2001; 16: 975-984.
Watts NB, Harris ST, Genant HK. Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. Osteoporosis Int 2001; 12: 429-437.
Olgaard K, Lewin E. Prevention of uremic bone disease using calciomimetic compounds. Ann Rev Med 2001; 52: 203-230.
Gardner DG. Hypercalcemia and sarcoidosis - another piece of the puzzle falls into place. Am J Med 2001; 110: 736-737.
OTROS ARTICULOS DE INTERÉS
Lees B, Stevson JC. The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17B and dydrogesterone. Osteoporosis Int 2001; 12: 251-258.
Trivedi DP, Khaw KT. Bon mineral density at the hip predicts mortality in elderly men. Osteoporosis Int 2001; 12: 259-265.
Khan SA, de Geus C, Holroyd B, Russell AS. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Int Med 2001; 161: 1.309-1.312.
Hinnie J, Bello E, McKillop E, Gallacher S. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 2001; 68: 216-218.
Kanis JA, Dawson A, Oden A, et al. Cost-effectiveness of preventing hip fracture in the general female population. Osteoporosis Int 2001; 12: 356-361.
Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporosis Int 2001; 12: 417-427.
Tabensky A, Duan Y, Edmonds J, Seeman E. The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures. J Bone Miner Res 2001; 16: 1.101-1.107.
Rymer J, Robinson J, Fogelman I. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss. Osteoporosis Int 2001; 12: 478-483.
Manson JE, Martin KA. Postmenopausal hormone-replacement therapy. New Eng J Med 2001; 345: 34-40.
Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. New Eng J Med 2001; 345: 66-67.
Sigurdsson G, Franzson L. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Int Med 2001; 250: 51-56.
Fujita T, Fujii Y, Okada SF, et al. Analgesic effect of etidronate on degenerative joint disease. J Bone Mineral Metab 2001; 19: 251-256.
Nichodemus KK, Folson AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24: 1.192-1.197.
Abrahamsen B, Stilgren LS, Hermann AP, et al. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women - Implications for assessment of bone loss and response to therapy. J Bone Miner Res 2001; 16: 1.212-1.219.
Caderette SM, Jaglal SB, Murray TM, et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorpiometry. JAMA 2001; 286: 57-63.
Villareal DT, Binder EF, Williams DB, et al. Bone mineral density response to estrogen replacement in frail elderly women. JAMA 2001; 286: 815-820.
Katabase K, Kato T, Hirai Y, et al. Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause: a randomized placebo-controlled study. Calcif Tissue Int 2001; 68: 223-228.
Garland DE, Adkins RH, Stewart CA, et al. Regional osteoporosis in women who have a complete spinal cord injury. J Bone Joint Surg Am 2001; 83: 1.195-1.200.
Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001; 57: 445-449.
Daniell HW. Osteoporosis due to androgen deprivation therapy in men with prostate cancer. Urology 2001; 58 (Supl 1): 101-106.
Chlebna-Sokol D, Loba-Jakuboska E. Sikora A. Clinical evaluation of patients with idiopathic juvenile osteoporosis. J Pediatr Orthop B 2001; 10. 259-263.
Millard TP, Antoniades L, Evans AV, et al. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 2001; 26: 446-448.
Kim KI, Han IK, Kim H, Cho NH. How reliable is the ultrasound densitometer for community screening to diagnose osteoporosis in spine, femur, and forearm? J Clin Densitom 2001; 4: 159-165.
Vasireddy S, Swinson DR. Male osteoporosis associated with longterm cyproterone treatment. J Rheumatol 2001; 28: 172-173.
Cruz DN, Wysolmerski JJ, Brickel HM, et al. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 2001; 72: 83-88.
Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001; 19: 3.306-3.311.
Newton J, Francis R, Prince M, et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 2001; 49: 282-287.